Doximity, Inc. (DOCS)

NYSE Currently down 0.56 (-2.21%) in today's trading session

1 member of Congress has disclosed 2 trades in Doximity, Inc. (DOCS) via STOCK Act filings. The most recent disclosure was a sale by Jonathan L. Jackson on 6 November 2025. Aggregate disclosed activity totals roughly $32.5K in purchases and $32.5K in sales (midpoint estimates from bracketed disclosure amounts).

Doximity, Inc. is currently trading at $24.74, positioned at 13% of its 52-week range ($17.15 – $76.51).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$24.74
24h Change
-0.56 (-2.21%)
52 Week Range
$17.15$76.51
View on NASDAQ

Doximity, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for DOCS

Select to highlight on chart
2 transactions
Compliance: 100%
Jonathan L. Jackson6 Nov 20255 Dec 2025SaleStock$15,001 - $50,000N/A
Jonathan L. Jackson25 Aug 202523 Sept 2025PurchaseStock$15,001 - $50,000-63.12%

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$4.63B

Volume

1.73M

Beta

1.21

P/E Ratio

16.17

Fundamentals

EPS

$1.53

Div. Yield

Open

$24.95

Day Range

$24.60 — $25.35

Company Information

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NYSE · USD
Country
US
CEO
Jeffrey A. Tangney
IPO Date
2021-06-24

Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, strea...

Earnings

Next Report

Q3 2026

5 Nov

EPS Est.

$0.34

Rev. Est.

$170.6M

Days Until

71

Recent Quarters

Q2 20266 Aug
EPS$0.29
Miss 4.3%
Q1 202613 May
EPS$0.26
Miss 7.1%
Q4 20255 Feb
EPS$0.46
Beat 4.5%
Q3 20256 Nov
EPS$0.45
Beat 18.8%
Q2 20257 Aug
EPS$0.36
Beat 19.4%
Q1 202515 May
EPS$0.38
Beat 39.9%
Q4 20246 Feb
EPS$0.45
Beat 45.2%
Q3 20247 Nov
EPS$0.30
Beat 20.0%
Q2 20248 Aug
EPS$0.28
Beat 27.3%
Q1 202416 May
EPS$0.25
Beat 25.0%
Q4 20238 Feb
EPS$0.29
Beat 26.1%
Q3 20239 Nov
EPS$0.22
Beat 22.2%
Q2 20238 Aug
EPS$0.19
Beat 26.7%
Q1 202316 May
EPS$0.20
Beat 17.6%
Q4 20229 Feb
EPS$0.22
Beat 22.2%
Q3 202210 Nov
EPS$0.17
Beat 6.3%
Q2 20224 Aug
EPS$0.14
Beat 40.0%
Q1 202217 May
EPS$0.21
Beat 40.0%
Q4 20218 Feb
EPS$0.29
Beat 123.1%
Q3 20219 Nov
EPS$0.19
Beat 90.0%
Q2 202110 Aug
EPS$0.11
Beat 37.5%
Q1 202125 Jun
EPS$0.10
Q4 202031 Mar
EPS$0.19
Q2 202030 Sept
EPS$0.06
Q1 202030 Jun
EPS$0.01
Q4 201931 Mar
EPS$0.04
Q3 201931 Dec
EPS$0.07

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about DOCS

Which members of Congress have traded DOCS?
1 member of Congress has disclosed 2 trade in Doximity, Inc. (DOCS) under the STOCK Act: Jonathan L. Jackson.
When was DOCS most recently disclosed by Congress?
The most recent DOCS disclosure was a sale by Jonathan L. Jackson on 6 November 2025.
What is the total disclosed congressional trading volume for DOCS?
Members of Congress have disclosed approximately $32.5K in DOCS purchases and $32.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in DOCS?
This DOCS page updates as soon as new STOCK Act disclosures are filed for Doximity, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.